DOCSLIB.ORG

Science of Genetically Engineered Crops (AKA Gmos)

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Science of Genetically Engineered Crops (AKA Gmos) Science of Genetically Engineered Crops (AKA GMOs) Margaret Smith Plant Breeding & Genetics Cornell University Topics • What is a “GMO”? • How is genetic engineering done? • Where are products from GE varieties found in our food and feed systems? What is a “GMO”? • It depends on who you ask! • Genetically modified organism – Organism = a plant, animal, or microbe – Foods are not organisms, thus not “GMO” – Food products or ingredients might come from a GMO • What is considered “genetically modified”? 2016 US Labeling Act • “Bioengineering” refers to a food: – “That contains genetic material that has been modified through in vitro recombinant DNA techniques; and – For which the modification could not otherwise be obtained through conventional breeding or found in nature.” UN FAO / WHO Definition “Genetically engineered/modified organisms, and products thereof, are produced through techniques in which the genetic material has been altered in a way that does not occur naturally by mating and/or natural recombination.” Which are “natural”? • Domestication • Farmer selection of new crops and varieties • Cross breeding • Genetic engineering Techniques that produce “GMO” varieties • Genetic engineering Techniques that produce “GMO” varieties • Genetic engineering • Cell or protoplast fusion? Techniques that produce “GMO” varieties • Genetic engineering • Cell or protoplast fusion? • Gene editing? Techniques that produce “GMO” varieties • Genetic engineering • Cell or protoplast fusion? • Gene editing? • Gene drives? Am I eating foods from genetically engineered crops? What foods contain GE crops? • 60-70% of supermarket foods have ingredients from a GE variety • Products made with soy or corn most obvious • Products with soy or corn derivatives • Limited fresh produce Food for Thought * * * * * * * * * * * * * * * * * * Ingredient may be made from a genetically-engineered organism The Food Supply GE Crops Non-GE Crops Harvesting Detection Equip. & Trucks DNA Protein Fresh Market Whole Foods Produce & Grain (corn, tomatoes...) Refined Processed Foods Ingredients (syrups, flours, oils) Nutrients & Derivatives Vitamins (Vitamins C, E…) Corn Wet Milling Source: Oregon State University Case in point: Original Cheerios Which ingredients could come from GE varieties? What is corn starch? • Mixture of amylose and amylopectin Amylose – Chains of glucose • No DNA, no protein What is beet (or cane) sugar? • Sucrose • No DNA, no protein Are the new Cheerios different? Summary • “GMO” ~ genetically engineered organism • Most are produced by introducing one or a few genes from an unrelated species – Cell/protoplast fusion? – Gene editing and gene drives?? • Ingredients from GE varieties are in many processed foods – Most are highly refined (purified) – No means to test if the source variety was GE or not... Thank you! Support from USDA-NIFA Smith Lever and Hatch Funds and Cornell’s College of Agriculture and Life Sciences is gratefully acknowledged..
Load more

Recommended publications
  • Gene Therapy and Genetic Engineering: Frankenstein Is Still a Myth, but It Should Be Reread Periodically
    Indiana Law Journal Volume 48 Issue 4 Article 2 Summer 1973 Gene Therapy and Genetic Engineering: Frankenstein is Still a Myth, but it Should be Reread Periodically George A. Hudock Indiana University - Bloomington Follow this and additional works at: https://www.repository.law.indiana.edu/ilj Part of the Genetics and Genomics Commons Recommended Citation Hudock, George A. (1973) "Gene Therapy and Genetic Engineering: Frankenstein is Still a Myth, but it Should be Reread Periodically," Indiana Law Journal: Vol. 48 : Iss. 4 , Article 2. Available at: https://www.repository.law.indiana.edu/ilj/vol48/iss4/2 This Article is brought to you for free and open access by the Law School Journals at Digital Repository @ Maurer Law. It has been accepted for inclusion in Indiana Law Journal by an authorized editor of Digital Repository @ Maurer Law. For more information, please contact [email protected]. GENE THERAPY AND GENETIC ENGINEERING: FRANKENSTEIN IS STILL A MYTH, BUT IT SHOULD BE REREAD PERIODICALLY GEORGE A. HUDOCKt Biotechnology and the law are far removed from each other as disciplines of human intellect. Yet the law and my own discipline, genetics, have come together in many courtrooms concerning such matters as paternity, and they will continue to intersect with increasing frequency as the visions of 100 years ago become the reality of today. This article examines the implications of recent research for human genetic therapy and genetic engineering, and suggests some guidelines for legal regulation of genetic technology. The following discussion derives from three premises which I view as basic: (1) that which is currently possible in genetic engineering, and in fact has already been done, is generally underestimated; (2) what may be possible in the near future is quite commonly overesti- mated; (3) regulation of the application of genetic technology is possible and will not be overwhelmingly complicated.
    [Show full text]
  • New Techniques of Genetic Engineering
    March 2016 New techniques of genetic engineering Why EU GMO law must be fully applied to the so-called ‘New Plant Breeding Techniques’ The European Commission is considering whether genetically modified organisms (GMOs) that have been produced through a range of new techniques should be excluded from the European Union’s GMO regulations. Biotechnology companies want to apply these techniques to engineer plants and animals for use in industrial food, biomass and biofuel production. They argue that these new methods to directly modify the genetic make-up of living organisms fall outside the scope of EU GMO regulations. This would mean that there is no risk assessment, labelling and monitoring of GM organisms produced by the new techniques and their derived products. The Commission has announced that it will present a legal analysis on the matter by the end of March 2016. The new GMOs present a real risk to the environment and human health. Legal analysis shows that they are covered by EU GMO law. If they were to escape EU regulations, any potential negative effects on food, feed or environmental safety would go unchecked. European consumers, farmers and breeders would have no way to avoid GMOs. The Commission should leave no doubt that all products of genetic engineering are subject to EU GMO law which requires rigorous risk assessment, detectability and labelling. 1 Which techniques are we talking about? The biotechnology industry and the European Commission use the term ‘New Plant Breeding Techniques’ to refer to a diverse set of genetic
    [Show full text]
  • Drawing the Line: Disability, Genetic Intervention and Bioethics
    laws Article Drawing the Line: Disability, Genetic Intervention and Bioethics Adam Conti Graduate student, Melbourne Law School, University of Melbourne, 185 Pelham St., Carlton, VIC 3053, Australia; [email protected] Received: 2 June 2017; Accepted: 10 July 2017; Published: 17 July 2017 Abstract: Meteoric scientific advances in genetic technologies with the potential for human gene editing intervention pose tremendous legal, medical, social, ethical and moral issues for society as a whole. Persons with disabilities in particular have a significant stake in determining how these technologies are governed at the international, domestic and individual levels in the future. However, the law cannot easily keep up with the rate of scientific progression. This paper aims to posit a methodology of reform, based on a core value of human dignity, as the optimal course of action to ensure that the interests of persons with disabilities, other possibly marginalised groups, and the scientific community, are balanced fairly. The paper critically analyses the current law and varying bioethical perspectives to ultimately conclude that a clear principled approach toward open discussion and consensus is of paramount importance to have any chance of devising an effective regulatory regime over human gene editing technology. Keywords: disability; human rights; genetics; gene editing; bioethics; governance; human dignity; eugenics; germline; Convention on the Rights of Persons with Disabilities The true good is in the different, not the same (Menand 2004). 1. Introduction Popular, professional and scholarly interest in genetics and their influence on human variability, behaviour and development has grown exponentially in recent years. In no small part has this interest been bolstered by mainstream media coverage of large-scale collaborative scientific initiatives like the Human Genome Project, which endeavoured to identify and map the human genome and determine the sequence of nucleotide base pairs that make up our DNA.
    [Show full text]
  • Genetic Engineering & Genetically Modified Organisms
    Genetic Engineering & Genetically Modified Organisms: Forming Informed Opinions By Smith, Lisa Scientific Theme(s): Science and Technology *Relationships among science, technology, and society Grade Level(s): 6-8 Lesson Duration: Designed for one 70 minute lesson Overview This lesson provides students an introduction to genetic engineering and genetically modified organisms, and raises student awareness of the potential Bias of availaBle information and the importance of forming informed, defendaBle opinions regarding controversial topics in science. The lesson was designed as an introduction for students to the genetic engineering and genetically modified organisms in preparation for a two-week research project exploring GMO topics, culminating with student presentations giving their opinions on the topics. Objectives Students will: 1. Define the term, ‘Biotechnology’. 2. Understand the difference Between selective Breeding and genetic engineering. 3. Identify different applications of genetic engineering, and recognize that all genetically engineered organisms are genetically modified organisms (GMOs). 4. Recognize Bias in print media, and to Be aware of the need to identify sources. 5. Understand the importance of forming informed, defendaBle opinions. Grade Level Expectations (GLEs) Addressed Science as Inquiry and Process [7] SA2.1 identifying and evaluating the sources used to support scientific statements Science and Technology [7] SE1.1 descriBing how puBlic policy affects the student’s life (e.g., puBlic waste disposal) [7] SE3.1 recognizing the effects of a past scientific discovery, invention, or scientific Breakthrough (e.g., DDT, internal comBustion engine) Required BacKground This lesson builds upon concepts covered in previous lessons on DNA, genes, and heredity. Students should have a solid understanding of the Basics of these concepts, including the idea that DNA is the “Blueprint” of life, that genes are coding regions of DNA, and that traits encoded By genes can Be inherited.
    [Show full text]
  • Highly Efficient Protoplast Isolation and Transient Expression System
    International Journal of Molecular Sciences Article Highly Efficient Protoplast Isolation and Transient Expression System for Functional Characterization of Flowering Related Genes in Cymbidium Orchids Rui Ren 1 , Jie Gao 1, Chuqiao Lu 1, Yonglu Wei 1, Jianpeng Jin 1, Sek-Man Wong 2,3,4, Genfa Zhu 1,* and Fengxi Yang 1,* 1 Guangdong Key Laboratory of Ornamental Plant Germplasm Innovation and Utilization, Environmental Horticulture Research Institute, Guangdong Academy of Agricultural Sciences, Guangzhou 510640, China; [email protected] (R.R.); [email protected] (J.G.); [email protected] (C.L.); [email protected] (Y.W.); [email protected] (J.J.) 2 Department of Biological Sciences, National University of Singapore (NUS), 14 Science Drive 4, Singapore 117543, Singapore; [email protected] 3 National University of Singapore Suzhou Research Institute (NUSRI), Suzhou Industrial Park, Suzhou 215000, China 4 Temasek Life Sciences Laboratory, National University of Singapore, 1 Research Link, Singapore 117604, Singapore * Correspondence: [email protected] (G.Z.); [email protected] (F.Y.) Received: 28 February 2020; Accepted: 24 March 2020; Published: 25 March 2020 Abstract: Protoplast systems have been proven powerful tools in modern plant biology. However, successful preparation of abundant viable protoplasts remains a challenge for Cymbidium orchids. Herein, we established an efficient protoplast isolation protocol from orchid petals through optimization of enzymatic conditions. It requires optimal D-mannitol concentration (0.5 M), enzyme concentration (1.2 % (w/v) cellulose and 0.6 % (w/v) macerozyme) and digestion time (6 h). With this protocol, the highest yield (3.50 107/g fresh weight of orchid tissue) and viability (94.21%) of × protoplasts were obtained from flower petals of Cymbidium.
    [Show full text]
  • Genetic Engineering (3500 Words)
    Genetic Engineering (3500 words) Biology Also known as: biotechnology, gene splicing, recombinant DNA technology Anatomy or system affected: All Specialties and related fields: Alternative medicine, biochemistry, biotechnology, dermatology, embryology, ethics, forensic medicine, genetics, pharmacology, preventive medicine Definition: Genetic engineering, recombinant DNA technology and biotechnology – the buzz words you may have heard often on radio or TV, or read about in featured articles in newspapers or popular magazines. It is a set of techniques that are used to achieve one or more of three goals: to reveal the complex processes of how genes are inherited and expressed, to provide better understanding and effective treatment for various diseases, (particularly genetic disorders) and to generate economic benefits which include improved plants and animals for agriculture, and efficient production of valuable biopharmaceuticals. The characteristics of genetic engineering possess both vast promise and potential threat to human kind. It is an understatement to say that genetic engineering will revolutionize the medicine and agriculture in the 21st future. As this technology unleashes its power to impact our daily life, it will also bring challenges to our ethical system and religious beliefs. Key terms: GENETIC ENGINEERING: the collection of a wide array of techniques that alter the genetic constitution of cells or individuals by selective removal, insertion, or modification of individual genes or gene sets GENE CLONING: the development
    [Show full text]
  • The Moral Dilemma of Genetically Modified Foods (Gmos)
    Fordham University Masthead Logo DigitalResearch@Fordham Student Theses 2001-2013 Environmental Studies 2005 The orM al Dilemma of Genetically Modified Foods (GMOs) Anamarie Beluch Follow this and additional works at: https://fordham.bepress.com/environ_theses Part of the Environmental Sciences Commons Recommended Citation Beluch, Anamarie, "The orM al Dilemma of Genetically Modified Foods (GMOs)" (2005). Student Theses 2001-2013. 72. https://fordham.bepress.com/environ_theses/72 This is brought to you for free and open access by the Environmental Studies at DigitalResearch@Fordham. It has been accepted for inclusion in Student Theses 2001-2013 by an authorized administrator of DigitalResearch@Fordham. For more information, please contact [email protected]. The Moral Dilemma of Genetically Modified Foods (GMOs) By Anamarie Beluch Genetically modified (GM) foods are foods that are produced from genetically modified organisms (GMO) that have had their DNA altered through genetic engineering. The process of producing a GMO used for genetically modified foods involve taking DNA from one organism, modifying it in a laboratory, and then inserting it into the target organism's genome to produce new and useful genotypes or phenotypes. These techniques are generally known as recombinant DNA technology. In recombinant DNA technology, DNA molecules from different sources are combined in vitro into one molecule to create a new gene. This DNA is then transferred into an organism and causes the expression of modified or novel traits. Such GMOs are generally referred to as transgenic, which means pertaining to or containing a gene or genes from another species. There are other methods of producing a GMO, which include increasing or decreasing the number of copies of a gene already present in the target organism, silencing or removing a particular gene, or modifying the position of a gene within the genome.
    [Show full text]
  • Enzymes for Cell Dissociation and Lysis
    Issue 2, 2006 FOR LIFE SCIENCE RESEARCH DETACHMENT OF CULTURED CELLS LYSIS AND PROTOPLAST PREPARATION OF: Yeast Bacteria Plant Cells PERMEABILIZATION OF MAMMALIAN CELLS MITOCHONDRIA ISOLATION Schematic representation of plant and bacterial cell wall structure. Foreground: Plant cell wall structure Background: Bacterial cell wall structure Enzymes for Cell Dissociation and Lysis sigma-aldrich.com The Sigma Aldrich Web site offers several new tools to help fuel your metabolomics and nutrition research FOR LIFE SCIENCE RESEARCH Issue 2, 2006 Sigma-Aldrich Corporation 3050 Spruce Avenue St. Louis, MO 63103 Table of Contents The new Metabolomics Resource Center at: Enzymes for Cell Dissociation and Lysis sigma-aldrich.com/metpath Sigma-Aldrich is proud of our continuing alliance with the Enzymes for Cell Detachment International Union of Biochemistry and Molecular Biology. Together and Tissue Dissociation Collagenase ..........................................................1 we produce, animate and publish the Nicholson Metabolic Pathway Hyaluronidase ...................................................... 7 Charts, created and continually updated by Dr. Donald Nicholson. DNase ................................................................. 8 These classic resources can be downloaded from the Sigma-Aldrich Elastase ............................................................... 9 Web site as PDF or GIF files at no charge. This site also features our Papain ................................................................10 Protease Type XIV
    [Show full text]
  • Morphological and Ultrastructural Changes in Bacterial Cells As an Indicator of Antibacterial Mechanism of Action
    Cell. Mol. Life Sci. DOI 10.1007/s00018-016-2302-2 Cellular and Molecular Life Sciences REVIEW Morphological and ultrastructural changes in bacterial cells as an indicator of antibacterial mechanism of action 1 2 2 T. P. Tim Cushnie • Noe¨lle H. O’Driscoll • Andrew J. Lamb Received: 24 April 2016 / Revised: 21 June 2016 / Accepted: 28 June 2016 Ó Springer International Publishing 2016 Abstract Efforts to reduce the global burden of bacterial highlighting those morphological and ultrastructural chan- disease and contend with escalating bacterial resistance are ges which are consistently induced by agents sharing the spurring innovation in antibacterial drug and biocide same mechanism (e.g. spheroplast formation by peptido- development and related technologies such as photody- glycan synthesis inhibitors) and explaining how changes namic therapy and photochemical disinfection. Elucidation that are induced by multiple antibacterial classes (e.g. fil- of the mechanism of action of these new agents and pro- amentation by DNA synthesis inhibitors, FtsZ disruptors, cesses can greatly facilitate their development, but it is a and other types of agent) can still yield useful mechanistic complex endeavour. One strategy that has been popular for information. Lastly, recommendations are made regarding many years, and which is garnering increasing interest due future study design and execution. to recent technological advances in microscopy and a deeper understanding of the molecular events involved, is Keywords Antibiotic Á Antiseptic Á Disinfectant Á the examination of treated bacteria for changes to their Mode of action Á SEM Á TEM morphology and ultrastructure. In this review, we take a critical look at this approach.
    [Show full text]
  • Definitions of GMO/LMO and Modern Biotechnology
    Chapter 23 Definitions of GMO/LMO and modern biotechnology JAN HUSBY NORWEGIAN INSTITUTE OF GENE ECOLOGY (GENØK), TROMSØ, NORWAY Three different definitions – but the same legal interpretation? There are many products coming from the field of gene technology that are not necessarily covered by today’s national biosafety regulations and the Cartagena Protocol on Biosafety. There are also many possible ways of interpreting the different existing definitions of Genetically Modified Organism (GMO) and Living Modified Organism (LMO). This includes the understanding of what gene technology and modern biotechnology constitute, something that may give rise to different regulations, including differences in legal coverage at the national level. The combined knowledge of biology, molecular genetics, techniques, and methodologies in combination with legal understanding and interpretation is necessary to outline the practical consequences of the definitions. In this chapter, I will take a closer look at the definition of GMO/LMO within the Cartagena Protocol, the EU directive 2001/18/EC and the Norwegian Gene Technology Act, and discuss possible similarities and differences in interpretation and understanding of what a GMO/LMO is. In the context of these definitions I mainly look at GMOs and LMOs as synonymous, but will also give some explanations as to possible different understandings of the two terms. The interpretation of what an LMO is in the Cartagena Protocol context needs to be made in the linkage between the definitions of ‘living modified organism’, ‘living organism’ and ‘modern biotechnology’, and is as follows: Cartagena Protocol; Article 3, Use of Terms g) ‘Living modified organism’ means any living organism that possesses a novel combination of genetic material obtained through the use of modern biotechnology; h) ‘Living organism’ means any biological entity capable of transferring or replicating genetic material, including sterile organisms, viruses and viroids; i) ‘Modern biotechnology’ means the application of: a.
    [Show full text]
  • Human Gene Therapy: Ethics and Public Policy*
    HUMAN G E N E T H E R A P Y 2:115-122 (1991) Mary A n n Liebert, Inc., Publishers Human Gene Therapy: Ethics and Public Policy* LEROY W A L T E R S ABSTRACT The first t h r e e h u m a n gene t r a n s f e r / t h e r a p y clinical p r o t o c o l s a r e n o w u n d e r w a y after h a v i n g b e e n s u b j e c t e d t o a n extensive review process b y t h e Recombinant D N A A d v i s o r y Committee (RAC) a n d i t s H u m a n Gene Therapy S u b c o m m i t t e e . T h e "Points t o C o n s i d e r " d o c u m e n t d e v e l o p e d b y t h e R A C established t h e f r a m e w o r k for e v a l u a t i n g genetic i n t e r v e n t i o n protocols. T h i s r e v i e w process is t a k i n g place in a b r o a d e r social c o n t e x t .
    [Show full text]
  • Gene Targeting in Plants
    The EMBO Journal vol.7 no.13 pp.4021 -4026, 1988 Gene targeting in plants Jerzy Paszkowski, Markus Baur, Although integration of transforming DNA into the Augustyn Bogucki and Ingo Potrykus homologous chromosomal DNA occurs efficiently in yeast, other fungi and Dictyostelium discoideum (Hinnen et al., Friedrich Miescher Institut, PO Box 2543, CH4002 Basel, 1978; De Lozanne et al., 1987; Miller et al., 1987), Switzerland non-homologous ('illegitimate') integration of foreign DNA Present address: Swiss Federal Institute of Technology, Institute of into the genome of higher eukaryotic cells makes it difficult Plant Sciences, ETH-Zentrum, Universitatstrasse 2, CH-8092 Zurich, to assay the frequency of gene targeting to a desired locus. Switzerland Only recently has the application of selection (Lin et al., Communicated by J.-D.Rochaix 1985; Thomas et al., 1986; Doetschman et al., 1987; Song et al., 1987; Thomas and Capecchi, 1987) and screening Although the generation of transgenic plants is now (Smithies et al., 1985) systems allowed comparison of the routine, the integration of foreign genetic information has frequencies of homologous and illegitimate integration of so far been at random sites in the genome. We now transformed DNA in cultured mammalian cells. In plants present evidence for directed integration into a predicted the high transformation frequencies reported for DNA location in the host plant genome. Protoplasts of molecules with no homology to the plant genome (Shillito transgenic tobacco (Nicotiana tabacum) plants carrying et al., 1985; Negrutiu et al., 1987) indicate efficient copies of a partial, non-functional drug-resistance gene illegitimate integration. Therefore, the detection of gene in the nuclear DNA were used as recipients for DNA targeting through homologous DNA recombination requires molecules containing the missing part of the gene.
    [Show full text]